Pasar al contenido principal

ALIMENTACION Y FUNCIONAMIENTO COGNITIVO: ¿TOMAMOS PEORES DECISIONES POR DISPONER DE DEMASIADA COMIDA, DEMASIADO FACIL DE CONSEGUIR?

PID2019-108250RJ-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDADE DA CORUÑA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Transcranial static magnetic stimulation reduces seizures in a mouse model of Dravet syndrome

  • Rivadulla, Casto
  • Pardo-Vázquez, José Luís
  • Labra, Carmen de
  • Aguilar, J.
  • Suárez, Eduardo
  • Paz, Concepción
  • Álvarez-Dolado, Manuel
  • Cudeiro, Javier
Dravet syndrome is a rare form of severe genetic epilepsy characterized by recurrent and long-lasting seizures. It appears around the first year of life, with a quick evolution toward an increase in the frequency of the seizures, accompanied by a delay in motor and cognitive development, and does not respond well to antiepileptic medication. Most patients carry a mutation in the gene SCN1A encoding the α subunit of the voltage-gated sodium channel Nav1.1, resulting in hyperexcitability of neural circuits and seizure onset. In this work, we applied transcranial static magnetic stimulation (tSMS), a non-invasive, safe, easy-to-use and affordable neuromodulatory tool that reduces neural excitability in a mouse model of Dravet syndrome. We demonstrate that tSMS dramatically reduced the number of crises. Furthermore, crises recorded in the presence of the tSMS were shorter and less intense than in the sham condition. Since tSMS has demonstrated its efficacy at reducing cortical excitability in humans without showing unwanted side effects, in an attempt to anticipate a possible use of tSMS for Dravet Syndrome patients, we performed a numerical simulation in which the magnetic field generated by the magnet was modeled to estimate the magnetic field intensity reached in the cerebral cortex, which could help to design stimulation strategies in these patients. Our results provide a proof of concept for nonpharmacological treatment of Dravet syndrome, which opens the door to the design of new protocols for treatment., Instituto de salud Carlos III (ISCIII) PI21/00151, co-funded by the European Union Xunta de Galicia, Grupos de referencia competitiva 2021 ED431C 2022/05 (CR) Ministerio de Ciencia e Innovacion PID2019-108250RJ-100 Xunta de Galicia, Grupos con Pontencial Crecimiento 2021 (JPV). Apoyo Dravet (MAD). JPV has a contract under the Ramon y Cajal program (RYC2019–026380-I)., Peer reviewed